BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$20.62 USD
+1.31 (6.78%)
Updated Jul 11, 2024 01:30 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
BLFS 20.62 +1.31(6.78%)
Will BLFS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BLFS
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
Other News for BLFS
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
Northland Securities Sticks to Their Buy Rating for BioLife Solutions (BLFS)
Top 4 July Stocks: Hot Month For S&P 500 (SA Quant)
BioLife Solutions (BLFS) Receives a Buy from Craig-Hallum
BioLife Solutions Introduces the CellSeal CryoCaseâ„¢ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver